BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 30452219)

  • 21. Murine recombinant angiotensin-converting enzyme 2 attenuates kidney injury in experimental Alport syndrome.
    Bae EH; Fang F; Williams VR; Konvalinka A; Zhou X; Patel VB; Song X; John R; Oudit GY; Pei Y; Scholey JW
    Kidney Int; 2017 Jun; 91(6):1347-1361. PubMed ID: 28249676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dysregulated Expression of microRNA-21 and Disease-Related Genes in Human Patients and in a Mouse Model of Alport Syndrome.
    Guo J; Song W; Boulanger J; Xu EY; Wang F; Zhang Y; He Q; Wang S; Yang L; Pryce C; Phillips L; MacKenna D; Leberer E; Ibraghimov-Beskrovnaya O; Ding J; Liu S
    Hum Gene Ther; 2019 Jul; 30(7):865-881. PubMed ID: 30808234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative trait loci influence renal disease progression in a mouse model of Alport syndrome.
    Andrews KL; Mudd JL; Li C; Miner JH
    Am J Pathol; 2002 Feb; 160(2):721-30. PubMed ID: 11839593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DDR1 role in fibrosis and its pharmacological targeting.
    Moll S; Desmoulière A; Moeller MJ; Pache JC; Badi L; Arcadu F; Richter H; Satz A; Uhles S; Cavalli A; Drawnel F; Scapozza L; Prunotto M
    Biochim Biophys Acta Mol Cell Res; 2019 Nov; 1866(11):118474. PubMed ID: 30954571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diabetic Vascular Calcification Mediated by the Collagen Receptor Discoidin Domain Receptor 1 via the Phosphoinositide 3-Kinase/Akt/Runt-Related Transcription Factor 2 Signaling Axis.
    Lino M; Wan MH; Rocca AS; Ngai D; Shobeiri N; Hou G; Ge C; Franceschi RT; Bendeck MP
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1878-1889. PubMed ID: 29930002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of discoidin domain receptors by imatinib prevented pancreatic fibrosis demonstrated in experimental chronic pancreatitis model.
    Bansod S; Saifi MA; Godugu C
    Sci Rep; 2021 Jun; 11(1):12894. PubMed ID: 34145346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DDR1 and DDR2 physical interaction leads to signaling interconnection but with possible distinct functions.
    Croissant C; Tuariihionoa A; Bacou M; Souleyreau W; Sala M; Henriet E; Bikfalvi A; Saltel F; Auguste P
    Cell Adh Migr; 2018; 12(4):324-334. PubMed ID: 29616590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A patent review of discoidin domain receptor 1 (DDR1) modulators (2014-present).
    Guo J; Zhang Z; Ding K
    Expert Opin Ther Pat; 2020 May; 30(5):341-350. PubMed ID: 32077340
    [No Abstract]   [Full Text] [Related]  

  • 29. Albumin contributes to kidney disease progression in Alport syndrome.
    Jarad G; Knutsen RH; Mecham RP; Miner JH
    Am J Physiol Renal Physiol; 2016 Jul; 311(1):F120-30. PubMed ID: 27147675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DDR1 contributes to kidney inflammation and fibrosis by promoting the phosphorylation of BCR and STAT3.
    Borza CM; Bolas G; Bock F; Zhang X; Akabogu FC; Zhang MZ; de Caestecker M; Yang M; Yang H; Lee E; Gewin L; Fogo AB; McDonald WH; Zent R; Pozzi A
    JCI Insight; 2022 Feb; 7(3):. PubMed ID: 34941574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of alpha3/alpha4(IV) collagen from the glomerular basement membrane induces a strain-dependent isoform switch to alpha5alpha6(IV) collagen associated with longer renal survival in Col4a3-/- Alport mice.
    Kang JS; Wang XP; Miner JH; Morello R; Sado Y; Abrahamson DR; Borza DB
    J Am Soc Nephrol; 2006 Jul; 17(7):1962-9. PubMed ID: 16769745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-microRNA-21 Therapy on Top of ACE Inhibition Delays Renal Failure in Alport Syndrome Mouse Models.
    Rubel D; Boulanger J; Craciun F; Xu EY; Zhang Y; Phillips L; Callahan M; Weber W; Song W; Ngai N; Bukanov NO; Shi X; Hariri A; Husson H; Ibraghimov-Beskrovnaya O; Liu S; Gross O
    Cells; 2022 Feb; 11(4):. PubMed ID: 35203245
    [No Abstract]   [Full Text] [Related]  

  • 33. The Role of Discoidin Domain Receptor 1 in Inflammation, Fibrosis and Renal Disease.
    Dorison A; Dussaule JC; Chatziantoniou C
    Nephron; 2017; 137(3):212-220. PubMed ID: 28743124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autosomal dominant form of type IV collagen nephropathy exists among patients with hereditary nephritis difficult to diagnose clinicopathologically.
    Imafuku A; Nozu K; Sawa N; Hasegawa E; Hiramatsu R; Kawada M; Hoshino J; Tanaka K; Ishii Y; Takaichi K; Fujii T; Ohashi K; Iijima K; Ubara Y
    Nephrology (Carlton); 2018 Oct; 23(10):940-947. PubMed ID: 28704582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PDGF-D Is Dispensable for the Development and Progression of Murine Alport Syndrome.
    Firat EAM; Buhl EM; Bouteldja N; Smeets B; Eriksson U; Boor P; Klinkhammer BM
    Am J Pathol; 2024 May; 194(5):641-655. PubMed ID: 38309427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-Based Design of Tetrahydroisoquinoline-7-carboxamides as Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors.
    Wang Z; Bian H; Bartual SG; Du W; Luo J; Zhao H; Zhang S; Mo C; Zhou Y; Xu Y; Tu Z; Ren X; Lu X; Brekken RA; Yao L; Bullock AN; Su J; Ding K
    J Med Chem; 2016 Jun; 59(12):5911-6. PubMed ID: 27219676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Neutralizing IL-11 Antibody Improves Renal Function and Increases Lifespan in a Mouse Model of Alport Syndrome.
    Widjaja AA; Shekeran SG; Adami E; Ting JGW; Tan J; Viswanathan S; Lim SY; Tan PH; Hübner N; Coffman T; Cook SA
    J Am Soc Nephrol; 2022 Apr; 33(4):718-730. PubMed ID: 35140116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dichotomy of the function of DDR1 in cells and disease progression.
    Yeh YC; Lin HH; Tang MJ
    Biochim Biophys Acta Mol Cell Res; 2019 Nov; 1866(11):118473. PubMed ID: 30954568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Collagen stimulates discoidin domain receptor 1-mediated migration of smooth muscle cells through Src.
    Lu KK; Trcka D; Bendeck MP
    Cardiovasc Pathol; 2011; 20(2):71-6. PubMed ID: 20093046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting of DDR1 with antibody-drug conjugates has antitumor effects in a mouse model of colon carcinoma.
    Tao Y; Wang R; Lai Q; Wu M; Wang Y; Jiang X; Zeng L; Zhou S; Li Z; Yang T; Yao Y; Wu Y; Yu L; Fu Y; Lai W; Peng Y; Lu Y; Zhang Z; Guo C; Zhang G; Gou L; Yang J
    Mol Oncol; 2019 Sep; 13(9):1855-1873. PubMed ID: 31116512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.